10005- A Phase 2 Study of Anti-PD-L1 Antibody MPDL3280A (Atezolizumab) in Alveolar Soft Part Sarcoma

Contact:

NCT Number:

Protocol:

AAAR3626

Study Status:

Active/Enrolling

Population:

Adult

Phase:

II

Principal Investigator